OXYGEN RADICAL TOXICITY AND CHRONIC NEURONAL LOSS
OXYGEN RADICAL TOXICITY AND CHRONIC NEURONAL LOSS
批准号:
6098634
负责人:
Jeffrey D Rothstein
金额:
$17.77万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-04-01 至 2000-03-31
关键词:
DNA damage antioxidants antisense nucleic acid apoptosis carbonyl group cytotoxicity free radical oxygen genetically modified animals glutamate receptor glutamates laboratory mouse laboratory rat lipid peroxides motor neurons neural degeneration neuropharmacology neuroprotectants neurotoxins neurotrophic factors organ culture oxidative stress peroxidation protooncogene spinal cord superoxide dismutase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Oxygen radicals and other radical species are toxic to cells, most often
by damaging membrane lipids and DNA. Cells have multiple levels of
antioxidant defenses, and superoxide dismutase is the first level of
defense against superoxide radicals. The notion that a gradual decrease
in these defenses might play a role in aging or neurodegenerative
diseases has been considered for years, but has remained controversial.
The recent discovery of mutations in the gene for Cu/Zn superoxide
dismutase (SOD1) in familial ALS provides the first good evidence that
a specific defect in antioxidant defenses could be responsible for a
neurodegenerative disease.
To determine whether decreased SOD activity could contribute to motor
neuron loss, we intend to model the chronic loss of SOD1 in spinal cord
organotypic cultures and then to use this model to investigate various
neuroprotective strategies:
(1) Toxicity Model: To develop a model of chronic oxidative toxicity
in organotypic spinal cord cultures. Is chronic inhibition of superoxide
dismutase toxic to motor neurons in spinal cord: We will develop a
rodent spinal cord organotypic culture system, then define susceptibility
of large cholinergic anterior horn cells to acute and chronic exposure
to SOD1 inhibition.
Significance: Creation of in vitro models allows for experimental
control and pharmacologic manipulation that is impossible in
patients.
(2) Using a model of chronic oxidative injury, can motor neuron loss be
prevented by antioxidants and other potential neuroprotectants:
Significance: Current knowledge of biochemical cascades operant in
programmed cell death suggest that neuronal toxicity induced
by oxidative stress might be blocked with both antioxidants and
neurotrophic factors. These studies will provide data on which
class of drugs might be most beneficial and specific to the
prevention of motor neuron death in ALS.
(3) The Bcl-2 family of natural antioxidants: Can the bcl-2 proto-
oncogene protect against the neurotoxicity of chronic oxidative stress?
Organotypic spinal cord cultures prepared from transgenic mice in which
Bcl-2 has either been knocked out or over-expressed will be used to study
the role of this putative mediator of antioxidant pathways as a natural
antioxidant or neuroprotectant.
Significance: Bcl-2 is a unique endogenous protein that can block
apoptotic death. As a natural antioxidant, it could function to
prevent chronic neural degeneration due to oxidative stress.
(4) Specificity: Does glutamate toxicity participate in the selective
targeting of motor neurons in models of oxidative stress?
Significance: Selective cell death is central to understanding the
pathogenesis of ALS as well as other neurodegenerative
processes.
These experiments will test the overall hypothesis that chronic excess
oxygen radical play an important pathophysiologic role in motor neuron
death. If this were true it would have fundamental consequences for our
understanding on chronic oxidative insults in neural degenerative
disorders and aging, and how to approach them neuropharmacologically.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nuclear and Glial Dysfunction in Neurodegeneration
-
批准号:10664230
-
项目类别:
-
资助金额:$122.81万
-
财政年份:2023
-
负责人:Jeffrey D Rothstein
-
依托单位:
Astrocyte Norrin, Norrie disease and Neurodegeneration
-
批准号:10383676
-
项目类别:
-
资助金额:$44.24万
-
财政年份:2019
-
负责人:Jeffrey D Rothstein
-
依托单位:
ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models
-
批准号:8613778
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2013
-
负责人:Jeffrey D Rothstein
-
依托单位:
ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models
-
批准号:8913279
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2013
-
负责人:Jeffrey D Rothstein
-
依托单位:
ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models
-
批准号:8724576
-
项目类别:
-
资助金额:$35.08万
-
财政年份:2013
-
负责人:Jeffrey D Rothstein
-
依托单位:
ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models
-
批准号:9314638
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2013
-
负责人:Jeffrey D Rothstein
-
依托单位:
ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models
-
批准号:8989628
-
项目类别:
-
资助金额:$4.05万
-
财政年份:2013
-
负责人:Jeffrey D Rothstein
-
依托单位:
ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models
-
批准号:9119869
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2013
-
负责人:Jeffrey D Rothstein
-
依托单位:
Small Molecule Induced Astrogliogenesis
-
批准号:7772961
-
项目类别:
-
资助金额:$20.5万
-
财政年份:2010
-
负责人:Jeffrey D Rothstein
-
依托单位:
Small Molecule Induced Astrogliogenesis
-
批准号:8078023
-
项目类别:
-
资助金额:$24.6万
-
财政年份:2010
-
负责人:Jeffrey D Rothstein
-
依托单位:
Therapeutic Expression of Glial Glutamate Transporters
-
批准号:7475723
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2005
-
负责人:Jeffrey D Rothstein
-
依托单位:
Therapeutic Expression of Glial Glutamate Transporters
-
批准号:7661618
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2005
-
负责人:Jeffrey D Rothstein
-
依托单位:
Characterizing Beta Lactams/Neuroprotective Drugs/ALS
-
批准号:6846528
-
项目类别:
-
资助金额:$39.74万
-
财政年份:2005
-
负责人:Jeffrey D Rothstein
-
依托单位:
Therapeutic Expression of Glial Glutamate Transporters
-
批准号:6952221
-
项目类别:
-
资助金额:$37.71万
-
财政年份:2005
-
负责人:Jeffrey D Rothstein
-
依托单位:
Characterizing Beta Lactams as Neuroprotectants for Amyotrophic Lateral Sclerosis
-
批准号:7259382
-
项目类别:
-
资助金额:$32.29万
-
财政年份:2005
-
负责人:Jeffrey D Rothstein
-
依托单位:
Characterizing Beta Lactams as Neuroprotectants for Amyotrophic Lateral Sclerosis
-
批准号:7800935
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2005
-
负责人:Jeffrey D Rothstein
-
依托单位:
Characterizing Beta Lactams as Neuroprotectants for Amyotrophic Lateral Sclerosis
-
批准号:7635845
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2005
-
负责人:Jeffrey D Rothstein
-
依托单位:
Therapeutic Expression of Glial Glutamate Transporters
-
批准号:7122886
-
项目类别:
-
资助金额:$36.92万
-
财政年份:2005
-
负责人:Jeffrey D Rothstein
-
依托单位:
Characterizing Beta Lactams/Neuroprotective Drugs/ALS
-
批准号:7019110
-
项目类别:
-
资助金额:$40.24万
-
财政年份:2005
-
负责人:Jeffrey D Rothstein
-
依托单位:
Therapeutic Expression of Glial Glutamate Transporters
-
批准号:7277647
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2005
-
负责人:Jeffrey D Rothstein
-
依托单位:
海外基金